Does pharmacological treatment of depression in people with a primary brain tumour bring any benefits? A Cochrane Review summary with commentary
BACKGROUND: Persons with primary brain tumour can suffer from depression. Depression may hinder rehabilitation intervention leading to further deterioration of patient's health and functioning. OBJECTIVE: The Cochrane Review aimed to assess the effectiveness and adverse effects of pharmacologic...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
IOS Press
2022
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/39604/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | BACKGROUND: Persons with primary brain tumour can suffer from depression. Depression may hinder rehabilitation intervention leading to further deterioration of patient's health and functioning. OBJECTIVE: The Cochrane Review aimed to assess the effectiveness and adverse effects of pharmacological treatment of depression in people with a primary brain tumour. METHODS: A Cochrane Review by Beevers et al. was summarized with comments. RESULTS: The reviewdid not find any eligible studies from the 2090 studies screened which included randomized controlled trials, cohort studies and case-control studies. CONCLUSIONS: There is no high-quality evidence as to whether pharmacological treatments for depression in people with primary brain tumours are either effective or harmful. |
|---|